Which antibiotic combo wins against h. pylori? a Head-to-Head test

NCT ID NCT07746934

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This trial compares two 14-day antibiotic combinations for treating Helicobacter pylori, a common stomach bacteria that can cause ulcers and stomach cancer. One combination uses metronidazole, the other uses a similar drug called tinidazole. The study will see if tinidazole is just as effective at eradicating the infection, while also comparing side effects and tolerability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Tinidazole-based bismuth quadruple therapy (tinidazole, esomeprazole, tetracycline, bismuth subcitrate) compared to metronidazole-based bismuth quadruple therapy
What this could lead to
If tinidazole works as well as metronidazole, doctors may have another effective option for treating H. pylori infections, potentially with fewer side effects.
What could go wrong
This is a head-to-head comparison, not a new drug discovery. The outcome depends on real-world effectiveness and tolerability, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Medicine and Pharmacy at Ho Chi Minh City

    Ho Chi Minh City, Ho Chi Minh, 70000, Vietnam

More trials for these conditions

Other studies related to the condition(s) this trial covers.